Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
AstraZeneca completes balcinrenone/dapagliflozin PK study; posts two new observational trialsOct 23Weekly roundup, 12 itemsabemaciclibAstraZeneca
Amgen recalls Sensipar and Corlanor lots; BKEMV biosimilar gets label updateJul 1Weekly roundup, 6 itemsAmgeneculizumab-aeeb